PhD, Professor, Board member
Previously President of group research at Roche, Professor Knowles was also a member of the Genentech Board for 12 years and of the Chugai Board for seven years. He was the first chairman of the Board of the IMI – Innovative Medicines Initiative – with a budget of more than 2 Billion Euros over five years. Jonathan was awarded the Scrip’s Lifetime Achievement Award in 2010 for his long academic and commercial career distinguished by his passion for personalized medicine. Board member of Herantis since 2009, Professor Knowles holds a PhD in Molecular Genetics from the University of East Anglia, England. He currently serves also e.g. as a Professor at the Institute for Molecular Medicine Finland (FIMM).